Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 193

1.

Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer.

Takeyama Y, Kato M, Tamada S, Azuma Y, Shimizu Y, Iguchi T, Yamasaki T, Gi M, Wanibuchi H, Nakatani T.

Cancer Lett. 2020 Mar 19;479:89-99. doi: 10.1016/j.canlet.2020.03.013. [Epub ahead of print]

PMID:
32200039
2.

Dimethylarsinic acid (DMA) enhanced lung carcinogenesis via histone H3K9 modification in a transplacental mouse model.

Fujioka M, Suzuki S, Gi M, Kakehashi A, Oishi Y, Okuno T, Yukimatsu N, Wanibuchi H.

Arch Toxicol. 2020 Mar;94(3):927-937. doi: 10.1007/s00204-020-02665-x. Epub 2020 Feb 12.

PMID:
32052077
3.

Promotion effects of acetoaceto-o-toluidide on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.

Yukimatsu N, Gi M, Okuno T, Fujioka M, Suzuki S, Kakehashi A, Yanagiba Y, Suda M, Koda S, Nakatani T, Wanibuchi H.

Arch Toxicol. 2019 Dec;93(12):3617-3631. doi: 10.1007/s00204-019-02605-4. Epub 2019 Oct 31.

PMID:
31673724
4.

Long-term administration of excess zinc impairs learning and memory in aged mice.

Yoshida K, Gi M, Fujioka M, Teramoto I, Wanibuchi H.

J Toxicol Sci. 2019;44(10):681-691. doi: 10.2131/jts.44.681.

5.

Phosphoethanolamine Accumulation Protects Cancer Cells under Glutamine Starvation through Downregulation of PCYT2.

Osawa T, Shimamura T, Saito K, Hasegawa Y, Ishii N, Nishida M, Ando R, Kondo A, Anwar M, Tsuchida R, Hino S, Sakamoto A, Igarashi K, Saitoh K, Kato K, Endo K, Yamano S, Kanki Y, Matsumura Y, Minami T, Tanaka T, Anai M, Wada Y, Wanibuchi H, Hayashi M, Hamada A, Yoshida M, Yachida S, Nakao M, Sakai J, Aburatani H, Shibuya M, Hanada K, Miyano S, Soga T, Kodama T.

Cell Rep. 2019 Oct 1;29(1):89-103.e7. doi: 10.1016/j.celrep.2019.08.087.

6.

A chronic toxicity study of diphenylarsinic acid in the drinking water of C57BL/6J mice for 52 weeks.

Yamaguchi T, Gi M, Fujioka M, Tago Y, Kakehashi A, Wanibuchi H.

J Toxicol Pathol. 2019 Jul;32(3):127-134. doi: 10.1293/tox.2018-0067. Epub 2019 Mar 21.

7.

PITX1 protein interacts with ZCCHC10 to regulate hTERT mRNA transcription.

Ohira T, Kojima H, Kuroda Y, Aoki S, Inaoka D, Osaki M, Wanibuchi H, Okada F, Oshimura M, Kugoh H.

PLoS One. 2019 Aug 12;14(8):e0217605. doi: 10.1371/journal.pone.0217605. eCollection 2019.

8.

Quantitative analysis of mutagenicity and carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in F344 gpt delta transgenic rats.

Gi M, Fujioka M, Totsuka Y, Matsumoto M, Masumura K, Kakehashi A, Yamaguchi T, Fukushima S, Wanibuchi H.

Mutagenesis. 2019 Sep 20;34(3):279-287. doi: 10.1093/mutage/gez015.

PMID:
31233596
9.

Acetoaceto-o-Toluidide Enhances Cellular Proliferative Activity in the Urinary Bladder of Rats.

Okuno T, Gi M, Fujioka M, Yukimatu N, Kakehashi A, Takeuchi A, Endo G, Endo Y, Wanibuchi H.

Toxicol Sci. 2019 Jun 1;169(2):456-464. doi: 10.1093/toxsci/kfz051.

PMID:
30796441
10.

[Refractory ascites caused by lymphatic flow disorder after stem cell transplantation for acute myeloid leukemia].

Takakuwa T, Okuno T, Nishimoto M, Nanno S, Takeoka Y, Nakashima Y, Koh H, Nakane T, Wanibuchi H, Hino M, Nakamae H.

Rinsho Ketsueki. 2019;60(1):12-16. doi: 10.11406/rinketsu.60.12. Japanese.

PMID:
30726817
11.

Establishment of a New Scirrhous Gastric Cancer Cell Line with FGFR2 Overexpression, OCUM-14.

Okuno T, Yashiro M, Masuda G, Togano S, Kuroda K, Miki Y, Hirakawa K, Ohsawa M, Wanibuchi H, Ohira M.

Ann Surg Oncol. 2019 Apr;26(4):1093-1102. doi: 10.1245/s10434-018-07145-2. Epub 2019 Jan 16.

PMID:
30652228
12.

Steroid sulfatase promotes invasion through epithelial-mesenchymal transition and predicts the progression of bladder cancer.

Shimizu Y, Tamada S, Kato M, Takeyama Y, Fujioka M, Kakehashi A, Nakatani T, Wanibuchi H, Gi M.

Exp Ther Med. 2018 Dec;16(6):4463-4470. doi: 10.3892/etm.2018.6787. Epub 2018 Sep 21.

13.

mTOR Activation in Liver Tumors Is Associated with Metabolic Syndrome and Non-Alcoholic Steatohepatitis in Both Mouse Models and Humans.

Okuno T, Kakehashi A, Ishii N, Fujioka M, Gi M, Wanibuchi H.

Cancers (Basel). 2018 Nov 22;10(12). pii: E465. doi: 10.3390/cancers10120465.

14.

Quantitative Approaches to Assess Key Carcinogenic Events of Genotoxic Carcinogens.

Fukushima S, Gi M, Fujioka M, Kakehashi A, Wanibuchi H, Matsumoto M.

Toxicol Res. 2018 Oct;34(4):291-296. doi: 10.5487/TR.2018.34.4.291. Epub 2018 Oct 15. Review.

15.

Chronic dietary toxicity and carcinogenicity studies of dammar resin in F344 rats.

Gi M, Fujioka M, Yamano S, Kakehashi A, Oishi Y, Okuno T, Yukimatsu N, Yamaguchi T, Tago Y, Kitano M, Hayashi SM, Wanibuchi H.

Arch Toxicol. 2018 Dec;92(12):3565-3583. doi: 10.1007/s00204-018-2316-7. Epub 2018 Sep 24.

PMID:
30251054
16.

In vivo positive mutagenicity of 1,4-dioxane and quantitative analysis of its mutagenicity and carcinogenicity in rats.

Gi M, Fujioka M, Kakehashi A, Okuno T, Masumura K, Nohmi T, Matsumoto M, Omori M, Wanibuchi H, Fukushima S.

Arch Toxicol. 2018 Oct;92(10):3207-3221. doi: 10.1007/s00204-018-2282-0. Epub 2018 Aug 27.

PMID:
30155721
17.

Generation of Rat Monoclonal Antibodies Against a Deubiquitinase, Ovarian Tumor Domain-Containing Protein 1.

Oikawa D, Shiota M, Goto E, Komakura K, Wanibuchi H, Tokunaga F.

Monoclon Antib Immunodiagn Immunother. 2018 Aug;37(4):180-184. doi: 10.1089/mab.2018.0023. Epub 2018 Aug 21.

PMID:
30130141
18.

Generation of Rat Monoclonal Antibodies Specific for DZIP3.

Oikawa D, Shiota M, Tokunaga F, Wanibuchi H.

Monoclon Antib Immunodiagn Immunother. 2018 Jun;37(3):153-157. doi: 10.1089/mab.2018.0005. Epub 2018 May 29.

PMID:
29812999
19.

Publisher Correction: Alpha-synuclein facilitates to form short unconventional microtubules that have a unique function in the axonal transport.

Toba S, Jin M, Yamada M, Kumamoto K, Matsumoto S, Yasunaga T, Fukunaga Y, Miyazawa A, Fujita S, Itoh K, Fushiki S, Kojima H, Wanibuchi H, Arai Y, Nagai T, Hirotsune S.

Sci Rep. 2018 May 17;8(1):8019. doi: 10.1038/s41598-018-25979-4.

20.

Hypoxia-inducible factor-2 alpha up-regulates CD70 under hypoxia and enhances anchorage-independent growth and aggressiveness in cancer cells.

Kitajima S, Lee KL, Fujioka M, Sun W, You J, Chia GS, Wanibuchi H, Tomita S, Araki M, Kato H, Poellinger L.

Oncotarget. 2018 Apr 10;9(27):19123-19135. doi: 10.18632/oncotarget.24919. eCollection 2018 Apr 10.

Supplemental Content

Loading ...
Support Center